Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
Clinical trial NCT04425252 · COMPLETED
Trial details
- NCT number
- NCT04425252
- Sponsor
- Clear Creek Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2020-12-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.